Skip to main content
Titan, CVS sign distribution deal for Probuphine implant
7/10/2019

Titan Pharmaceuticals and CVS Health's CVS Caremark have entered a deal to distribute Titan's Probuphine subdermal implant, a buprenorphine-delivery implant designed for patients with opioid use disorder. Titan expects the specialty pharmacy distribution system to account for most of the implant's sales in the US.

Full Story: